Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Ultrasound Obstet Gynecol ; 49(3): 387-393, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27062653

ABSTRACT

OBJECTIVES: To describe changes in umbilical artery (UA) Doppler flow in monochorionic diamniotic (MCDA) twins affected by selective intrauterine growth restriction (sIUGR), to correlate Doppler findings with pregnancy course and perinatal outcome, and to report postnatal follow-up. METHODS: This was a retrospective study of 140 MCDA twins with sIUGR. UA end-diastolic flow, defined as Doppler waveform pattern Type I (persistently positive), Type II (persistently absent or persistently reversed) or Type III (intermittently absent or intermittently reversed), was recorded at first examination and monitored weekly until double or single intrauterine fetal death (IUFD), bipolar cord coagulation or delivery. All neonates had an early neonatal brain scan, magnetic resonance imaging, when indicated, and neurological assessment during infancy. Rates (per 100 person-weeks) and hazard ratios (HR) of IUFD in the IUGR twin in each pregnancy were calculated considering UA Doppler pattern as a time-dependent variable. RESULTS: At first examination, there were 65 cases with UA Doppler waveform pattern Type I, 62 with Type II and 13 with Type III. Of the 65 Type-I cases, 48 (74%) remained stable, while 17 (26%) changed to either Type II absent (14%), Type II reversed (9%) or Type III (3%). Of 62 Type-II cases (47 with absent and 15 with reversed flow), 33 (53%) remained stable (18 with absent and all 15 with reversed flow). The 29 Type-II absent cases which changed became Type II reversed (24/47, 51%) or Type III (5/47, 11%). All 13 Type-III cases remained stable. Compared with Type I, the risk of IUFD (adjusted for estimated fetal weight discordance and amniotic fluid deepest vertical pocket) was highest when the pregnancy was or became Type II reversed (HR, 9.5; 95% CI, 2.7-32.7) or Type II absent (HR, 4.3; 95% CI, 1.3-14.3). Mild neurological impairment was more prevalent in the IUGR twin than in the large cotwin (7% vs 1%, P = 0.02). CONCLUSIONS: Risk stratification based on UA Doppler is useful for planning ultrasound surveillance. However, patterns can change over time, with important consequences for management and outcome. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Diseases in Twins/diagnostic imaging , Fetal Growth Retardation/diagnostic imaging , Ultrasonography, Doppler/methods , Ultrasonography, Prenatal/methods , Umbilical Arteries/diagnostic imaging , Adult , Female , Humans , Maternal Age , Predictive Value of Tests , Pregnancy , Pregnancy Outcome , Retrospective Studies , Twins, Monozygotic , Young Adult
2.
Neurology ; 63(6): 1053-8, 2004 Sep 28.
Article in English | MEDLINE | ID: mdl-15452297

ABSTRACT

BACKGROUND: Glycogen storage disease type IV (GSD-IV) is a clinically heterogeneous autosomal recessive disorder due to glycogen branching enzyme (GBE) deficiency and resulting in the accumulation of an amylopectin-like polysaccharide. The typical presentation is liver disease of childhood, progressing to lethal cirrhosis. The neuromuscular form of GSD-IV varies in onset (perinatal, congenital, juvenile, or adult) and severity. OBJECTIVE: To identify the molecular bases of different neuromuscular forms of GSD-IV and to establish possible genotype/phenotype correlations. METHODS: Eight patients with GBE deficiency had different neuromuscular presentations: three had fetal akinesia deformation sequence (FADS), three had congenital myopathy, one had juvenile myopathy, and one had combined myopathic and hepatic features. In all patients, the promoter and the entire coding region of the GBE gene at the RNA and genomic level were sequenced. RESULTS: Nine novel mutations were identified, including nonsense, missense, deletion, insertion, and splice-junction mutations. The three cases with FADS were homozygous, whereas all other cases were compound heterozygotes. CONCLUSIONS: This study expands the spectrum of mutations in the GBE gene and confirms that the neuromuscular presentation of GSD-IV is clinically and genetically heterogeneous.


Subject(s)
1,4-alpha-Glucan Branching Enzyme/genetics , Genetic Heterogeneity , Glycogen Storage Disease Type IV/genetics , Mutation , 1,4-alpha-Glucan Branching Enzyme/chemistry , 1,4-alpha-Glucan Branching Enzyme/deficiency , Adult , Age of Onset , Amino Acid Substitution , Cells, Cultured/enzymology , Child , Child, Preschool , Consanguinity , DNA/genetics , DNA Mutational Analysis , Erythrocytes/enzymology , Fatal Outcome , Fibroblasts/enzymology , Genotype , Glycogen Storage Disease Type IV/enzymology , Glycogen Storage Disease Type IV/epidemiology , Glycogen Storage Disease Type IV/pathology , Humans , Hydrogen Bonding , Hydrophobic and Hydrophilic Interactions , Infant , Infant, Newborn , Liver/pathology , Models, Molecular , Muscles/enzymology , Muscles/pathology , Phenotype , Protein Conformation , RNA Splice Sites/genetics , Sequence Deletion
4.
Acta Biomed Ateneo Parmense ; 71 Suppl 1: 633-6, 2000.
Article in Italian | MEDLINE | ID: mdl-11424819

ABSTRACT

Gastroesophageal reflux (GER) is very common in infants, especially in prematures and may be cause of gastrointestinal and cardiorespiratory symptoms. Cisapride, a prokinetic agent, is used in order to avoid the transient esophageal sphincter relaxation, but it is sometimes associated to transient prolongation of QT interval on EKG, especially with high dosage. The authors report the effects of cisapride therapy (0.8 mg/Kg/day) on QTc interval (QTc = QT interval corrected on heart frequency) in a pediatric population (50 infants) with GER. Results demonstrate the relatively safety of cisapride therapy at low dose also in the pediatric period.


Subject(s)
Cisapride/therapeutic use , Electrocardiography/drug effects , Gastroesophageal Reflux/drug therapy , Gastroesophageal Reflux/physiopathology , Gastrointestinal Agents/therapeutic use , Infant, Premature, Diseases/drug therapy , Infant, Premature, Diseases/physiopathology , Ranitidine/therapeutic use , Humans , Infant, Newborn
5.
Pediatr Med Chir ; 17(3): 275-7, 1995.
Article in Italian | MEDLINE | ID: mdl-7567654

ABSTRACT

Newborns with vascular catheters must be investigated by echocardiogram for intracardiac thrombosis. We report the use of urokinase to treat an asymptomatic right atrial thrombus in a 31 weeks' gestation newborn; the thrombosis occurred after placement of a catheter in the umbilical vein. We obtained a safe and successful thrombolysis using urokinase 4000 U/kg/h in continuous infusion.


Subject(s)
Catheterization, Peripheral/adverse effects , Heart Diseases/drug therapy , Thrombolytic Therapy/methods , Thrombosis/drug therapy , Umbilical Veins , Urokinase-Type Plasminogen Activator/administration & dosage , Echocardiography , Gestational Age , Heart Atria/diagnostic imaging , Heart Diseases/diagnostic imaging , Heart Diseases/etiology , Humans , Infant, Newborn , Male , Thrombosis/diagnostic imaging , Thrombosis/etiology
6.
Pediatr Med Chir ; 15(6): 583-4, 1993.
Article in Italian | MEDLINE | ID: mdl-8197018

ABSTRACT

The Authors describe the clinical history and diagnostical problems of a premature twin with the three classical symptoms cough-vomiting-growth retardation in the first year of life. Is the diagnostic route required to stabilize whether this condition is primarily gastroenterological or pulmonary?


Subject(s)
Bronchopneumonia/diagnosis , Cough/etiology , Diseases in Twins , Gastroesophageal Reflux/diagnosis , Infant, Premature, Diseases/diagnosis , Vomiting/etiology , Bronchopneumonia/complications , Chronic Disease , Cough/complications , Gastroesophageal Reflux/complications , Growth Disorders/etiology , Humans , Infant , Infant, Newborn , Infant, Premature , Male , Pulmonary Emphysema/complications , Pulmonary Fibrosis/complications , Vomiting/complications
7.
Pediatr Med Chir ; 5(6): 579-82, 1983.
Article in Italian | MEDLINE | ID: mdl-6681063

ABSTRACT

13 preterm infants (gestational age 34 weeks or below; birth weight under 1500 g.) with severe respiratory distress, were admitted for intensive care in our Unit between 1980 and 1981. Factors affecting the onset of BPD (bronchopulmonary dysplasia) in these subjects are evaluated by retrospective studies. Diuresis in the third day of life, expressed as a percentage of administered fluids appeared particularly significant. It resulted significantly lower in subjects developing BPD than in non-affected controls. Therefore, along with a PDA and a high fluid input favouring interstitial oedem, the inability of preterm infants to remove fluid overload must be considered. A reduced clearance of interstitial fluid in the lung enhances circulatory status and ventilatory damage and increases the risk of BPD.


Subject(s)
Bronchopulmonary Dysplasia/etiology , Diuresis , Humans , Infant, Newborn , Respiratory Distress Syndrome, Newborn/therapy , Retrospective Studies , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...